AllPennyStocks.com

Teaching Investors How To Turn Pennies Into Dollars TM


Subscribe to our free newsletter:

 Quote:   Symbol Lookup  (TSX = T.xxx, TSX-V = V.xxx)


Advertising    Contact Us    Message Boards
 
   

American Company Spotlight

 

MedSpas of America, Inc. Website: Click Here

Information As Of January 7, 2008

Exchange: Pink Sheets Market Cap: 1.2 Million
Outstanding Shares: 17.7 Million 52 Low / High: $0.04 / $1.00

Price January 7, 2008: $0.07

MEDP Recent Stock Quote and News: Click Here

'Jim Cramer, the financial guru from MSNBC stated “Companies with products to help the eyesight, skin care and plastic surgery will be big winners.”'


Overview

MedSpas of America, Inc., headquartered in Atlanta, Georgia, is building a corporation that specializes in niche markets of the medical spa industry, what industry experts are calling "the fastest growing segment of the medical industry." The Company is expanding into three distinct areas of the medspa industry, those being: (a) medspa operations; (b) medspa services and supplies; and (c) education. The diversification into these vertical markets balances the company's potential cash and enhances long-term shareholder value.


Investment Highlights

  • In 2004, consumers spent $44.6 billion on anti-aging products and services, and the total anti-aging market is projected to reach $72 billion by 2009 (Business Communications Co., Inc., February 2005).
  • The Company has established a new division to penetrate the $5.4 billion cosmeceutical industry under the brand name Natural Renu.
  • US cosmeceuticals demand will grow 8.5 percent annually, propelled by a stream of new products offering age-defying and other appearance-enhancing benefits.
  • In the medspa operational niche, the company is developing a national medspa chain under the brand name of Virtuoso MedSpas.
  • Studies show the number of Americans over 55 will grow by 60% in the next 20 years and their buying power will exceed $2 trillion by 2007.
  • The company signed a Joint Venture Development Agreement with Solana MedSpas in the fourth quarter of 2006. Solana MedSpas has agreed to provide development services, operational oversight and access to their management team for the Company with the intent to build a company owned chain of a minimum of 50 Medical Spas, under the brand name of Virtuoso Medical Spas, in the United States over the next 5-years.
  • Only 10 % to 15% of demand for medspa services is currently being met in the U.S. marketplace.
  • The Company recently signed an exclusive worldwide agreement with Zymetech, for the exclusive use of Penzim as the essential ingredient in the anti-aging line of products for Natural Renu. Zymetech owns the worldwide patents for an active ingredient called Penzyme derived from enzymes produced by fish, particularly cod in the North Atlantic. This enzyme has been clinically tested for the treatment of pain, inflammation, arthritis, bursitis, eczema, psoriasis, fybromyalgia, eczema, acne and other skin conditions, such as itching, dry skin and brown spots.
  • A survey by the New American Academy of Dermatology found that 69% of women are bothered by signs of aging, particularly fine lines, wrinkles, uneven skin tone, facial hair and dryness.


Profile

MedSpas of America, Inc. is headquartered in Atlanta, Georgia, and is building a corporation in the professional and high-end skin care markets, generally referred to as the “anti-aging” market. This fast growing market sector is being predominantly driven by the aging “baby boomer” demographic sector. Most business professionals agree that the demand for skincare products is going to increase as baby boomers age. In fact, Jim Cramer, the financial guru from MSNBC stated “Companies with products to help the eyesight, skin care and plastic surgery will be big winners.”

The Company has chosen two entry points into this large and fast growing market, those being: (a) the $5.4 billion cosmeceutical and nutraceutical industry; and (b) the $9.4 billion cosmetic procedures and medical spa market niche, what industry experts are calling “the fastest growing segment of the medical industry.” These two markets have significant synergy as they place the Company on both the services and supply side of one of America’s fastest growing industries.

The Company will achieve its growth goals through a national branding strategy of its developing skin care products line called Natural Renu and its medical spa brand called Virtuoso Medspa. The Natural Renu line is currently under development and will be market through distribution channels of Internet Retailing and Professional use in spas, cosmetic and medical aesthetician environments.


Natural Renu

The company has established a new division to penetrate the $5.4 billion cosmeceutical industry under the brand name Natural Renu. The company’s new initiative will be a line of cosmeceutical products focusing on the anti aging and skin healthcare markets. The action reflects the Company's belief in both the strength of the market and the strength of its brand positioning as a key service provider in the markets niches of Plastic Surgeons and Dermatology practices, medical spa’s and day spa’s.

The new division will operate under the brand name of Natural Renu. The company will focus its sales efforts primarily through two marketing channels. The first and primary sales channel shall be Internet Retailing. By utilizing its existing skill set and marketing prowess in this area, the company shall initiate an intensive online awareness campaign and drive potential users of this type of product to its web site. The second target audience shall be to exclusive Plastic Surgeons and Dermatology practices, Day spas, Resorts and Medspas around the world.

According to, Nutrition Science News, the term "cosmeceuticals" was coined after numerous products emerged on the market that combined common cosmetic preparations with nutraceuticals. Cosmeceutical ingredients are most often used in products for anti-aging purposes. US cosmeceuticals demand will grow 8.5 percent annually, propelled by a stream of new products offering age-defying and other appearance-enhancing benefits. Skin care products will remain dominant while professional products will grow the fastest.


Virtuoso Medspas

In the medspa operational niche, the company is developing a national medspa chain under the brand name of Virtuoso MedSpas. Virtuoso was founded by leading practitioners and accomplished executives in response to the growing marketplace demand for technology-based medical spa facilities. The standard Virtuoso medical spa model consists of a 2,000 square foot leased facility located in a high-end, retail shopping environment. Virtuoso offers non-invasive cosmetic skin-care procedures in a spa setting and supervised by medical practitioners. The Company’s expansion plans are to acquire existing medical spas that are strategically located and convert those medical spas to the Virtuoso brand.


Solana Medspas Joint Venture

The company signed a Joint Venture Development Agreement with Solana MedSpas of Irvine, California, www.solanamedspa.com in the fourth quarter of 2006. Under the terms of the MedSpa Development Joint Venture, Solana MedSpas has agreed to provide development services, operational oversight and access to their management team for the company with the intent to build a company owned chain of a minimum of 50 Medical Spas, under the brand name of Virtuoso Medical Spas, in the United States over the next 5-years. The services provided by Solana will include site selection and build-out of new MedSpas, design services, equipment and supplies procurement, medical protocol and operating systems, recruitment and training of MedSpa staffing, medical regulatory compliance, and marketing programs. Both Solana MedSpas and MDSP have agreed to focus the company’s initial development program on the acquisition and conversion of existing MedSpa businesses that are not currently in the national Solana MedSpas network.


Recent Acquisition – Natural Skin Care Line

Following the company’s announcement of October 8, 2007, the company recently completed the acquisition of the luxury natural skin care lines from 2M Innovations LTD.

The company acquired 2 professional skin care lines from 2M Innovations including a line of 16 natural skin care products. The Company's all-natural products contain a uniquely exotic and effective combination of hibiscus flower and kukui nut oil. The Company will immediately re-brand this product line to its Natural Renu brand to become the foundation of the Company’s retail natural skin care line. The second line of products, called doceuticals™, is an all-natural line of skin care products that is marketed towards physicians, aestheticians and medspas.


Market Summary

Only 10 % to 15% of demand for medspa services is currently being met in the U.S. marketplace. Americans spent just under $9.4 billion on cosmetic medical procedures in 2003. In 2004, consumers spent $44.6 billion on anti-aging products and services, and the total anti-aging market is projected to reach $72 billion by 2009 (Business Communications Co., Inc., February 2005). Market indicators point to the consumer’s preference for non-surgical treatments. 2,000 Americans will turn 50 every day (1 every 8 seconds) for the next 20 years. Studies show the number of Americans over 55 will grow by 60% in the next 20 years and their buying power will exceed $2 trillion by 2007.


Demographic and Economic Trends

The MedSpa revolution has been closely linked to the growing baby boomer generation in the US. Baby boomers are generally considered to be persons born during the post-World War II birth rate boom, lasting from 1946 through about 1964. As a group, they are well educated, with 87 percent being high school graduates and one in four a college graduate. They are the wealthiest, most sophisticated purchasers. At approximately 75 million, baby boomers are the single largest buying group in the US today.

  • Baby-boomers make up 51% of the population, controlling 75% of the country’s wealth
  • 12,000 Americans turn 50 every day (1 every 8 seconds)
  • Americans over 55 will grow by 60% in the next 20 years and their buying power will exceed $2 trillion by 2007
  • 80 million people in the U.S. spend $500 million annually in hair removal procedures like waxing, shaving, and accessories
  • Over 1 million women spend over $1 billion each year on electrolysis and lasers
  • Ethnic markets in the U.S. spent $1.5 billion in health and beauty products in 2003.

While baby boomers are largely considered the main target medspa consumers, the variety of treatments and services available in medspas expand this consumer base even further. Laser Hair Removal, Acne Programs, Deep Tissue Facials and non-surgical Cellulite Treatments attract men and women well outside the baby boomer bracket.

A survey by the New American Academy of Dermatology found that 69% of women are bothered by signs of aging, particularly fine lines, wrinkles, uneven skin tone, facial hair and dryness. In the above 45 category, women feel their facial skin makes them look older than they feel inside.


Products & Services

Natural Renu Cosmeceuticals

The company has established a new division to penetrate the $5.4 billion cosmeceutical industry under the brand name Natural Renu. The company’s new initiative is a line of nutraceutical and cosmeceutical products focusing on the anti aging skin care market.

The company will focus its sales efforts primarily through two marketing channels. The first and primary sales channel shall be the Internet. By utilizing its existing skill set and marketing prowess in this area, the company shall initiate an intensive online awareness campaign and drive potential users of this type of product to its web site. The second target audience shall be to plastic surgeons, dermatologists, aestheticians, Day spas, Resorts Spas and Medspas around the world.

Natural Renu with Penzim

The company recently signed an exclusive worldwide agreement with Zymetech from Reykjavick, Iceland, www.zymetech.com, for the exclusive use of Penzim as the essential ingredient in the anti-aging line of products for Natural Renu.

Zymetech owns the worldwide patents for an active ingredient called Penzyme derived from enzymes produced by fish, particularly cod in the North Atlantic. This enzyme has been clinically tested for the treatment of pain, inflammation, arthritis, bursitis, eczema, psoriasis, fybromyalgia, eczema, acne and other skin conditions, such as itching, dry skin and brown spots.

Through the agreement with Zymetech, the Company has signed a manufacturing and fulfillment agreement with GeoPharma, Inc., www.geopharmainc.com, to manufacture Natural Renu and provide fulfillment for the company’s customer orders. GeoPharma is located in Largo, Florida.

Natural Skin Care Line/Doceuticals

The Company recently closed an acquisition of a skin care line from 2M Innovations (see announcement of October 8, 2007) and a cosmeceutical brand called Doceuticals. The company acquired 2 professional skin care lines from 2M Innovations including a line of 16 natural skin care products. The Company's all-natural products contain a uniquely exotic and effective combination of hibiscus flower and kukui nut oil. The Company will immediately re-brand this product line to its Natural Renu brand to become the foundation of the Company’s retail natural skin care line. The second line of products, called doceuticals™, is an all-natural line of skin care products that is marketed towards physicians, aestheticians and medspas.

The Company is in the process of converting this natural skin care line to Natural Renu giving their brand an additional sixteen product lines as follows:

Product Size & Retail Pricing

FACE -
Ultra-Moisturizing Citrus Cleanser 8 oz.
Island Grapefruit Face Polish 2 oz.
Cucumber Toner 8 oz.
Ultra-Light Face Crème 4 oz.
Island Rose Facial Moisturizer 4 oz.
Ultra-Nourishing Antioxidant Crème 2 oz.
Revitalizing Eye & Lip Crème 2 oz.

BODY -
Island Citrus Body Polish 8 oz.
Bora Bora Body Butter 8 oz.
Island Citrus Body Wash 8 oz.
Shea Butter Body Lotion 8 oz.
Mint & Eucalyptus Foot Lotion 4 oz.

TREATMENT -
Mint & Eucalyptus Body Treatment 8 oz.
Lavender Face Treatment 4 oz.
Polynesian Facelift 1 oz.
Passion Fruit & Kiwi Face Masque 4 oz.

The Doceutical product line development will be ready for market in the Fall of 2008. This product line is a cosmeceutical that is targeted for use by medical aestheticians in medical spas and physicians offices.

Brand Re-Seller

As an added feature to the Company's internet retailing strategy, Natural Renu will offer its online customers the ability to purchase the other major nutraceutical and cosmeceutical brands available in the marketplace. The Company will act as a re-seller of those brands. Although the profit margin from re-seller is much less than The Company's own brands, they will substantially enhance their revenues.

As a re-seller, Natural Renu will offer over 60 brands including internationally known products such as Obagi, Bioelement and Prevage. These product lines, as mandated by the manufacturers, can only be sold by retailers that employ licensed estheticians. Furthermore, these products have a well-established demand and customer base. Moreover, these products are intensively marketed by the manufacturers themselves, thus, adding an additional element of credibility to The Company's website.

Virtuoso Medspa Services

Procedures are performed by certified technicians under the supervision of licensed physicians, including:

  • FotoFacial RF™
  • Laser Hair Removal
  • Laser Vein Removal
  • IPL Laser Acne Treatment

Injectibles

Procedures are performed by licensed physicians, including:

  • BOTOX® Cosmetic
  • Restylane®

Aesthetic Services

Procedures are performed by certified aestheticians under the supervision of licensed physicians, including:

  • Vibradermabrasion
  • Corrective Facials
  • Corrective Acne Treatments
  • Extreme Skin Rejuvenation
  • Alpha/Beta Peel
  • Amino Fruit Acid Clay Peel
  • Live Stem Cell Skin Therapy

Recent News and Press Releases

MedSpas of America Completes Skin Care Line Acquisition (Mon, Jan 7)

Medspas of America Hits CEOCorner at InvestSourceInc.com (Thu, Dec 20)

MedSpas of America Signs Letter of Intent to Acquire South Seas Spa(TM) (Mon, Oct 8)

MedSpas of America Selects Mediahost to Manage E-commerce Growth (Wed, Oct 3)

MedSpas of America Selects BlueBox Interactive Studios to Power Explosive Growth (Wed, Sep 26)

Medspas of America Signs Manufacturing Agreement for Natural Renu (Thu, Sep 20)

Medspas of America Signs Exclusive Agreement for Natural Renu (Wed, Aug 15)

Medspas of America Enters Cosmeceutical Market With Natural Renu (Mon, Aug 13)

Medspas of America Acquires Medbizmarket (Mon, Jul 16)

MedSpas Releases CEO Letter to Shareholders Describing Diversification Plans (Thu, Jul 12) 


Management

Paul R. Smith, HBA, Chief Executive Officer. Mr. Smith has a 30-year career as a senior executive with extensive experience in management in private and public corporations. Mr. Smith has held senior executive positions as President of York Hannover, a $300 million hotel and leisure company; CEO of MedSpas of America, Inc., a publicly-traded holding company; CEO of Foodvision.com, Inc., a publicly-traded hi-tech hospitality Internet company; and President of PRS Hospitality, Inc., a boutique hospitality consulting company with clients worldwide. Mr. Smith holds an honors business degree from Richard Ivey School of Business, a Harvard affiliate and Canada’s most prestigious business school.

Dr. Walter G. Mayfield, Sr. D.O., Chief Medical Officer Dr. Mayfield is an accomplished physician with specialties in family practice and pharmacy. Dr. Mayfield is the founder of Mountain Park Family Practice, Atlanta Georgia. Dr. Mayfield has held positions as: Chairman of the Department of Family Practice for Northlake Regional Medical Center; Chief of Staff at Northlake Regional Medical Center; Member of the Board of Directors of Northlake Regional Medical Center; and Member of the Board of Directors of Georgia Osteopathic Hospital Inc. Dr. Mayfield received his Doctorate of Osteopathy at the University of Health Sciences in Kansas City, Missouri and degree in Pharmacy at the University of Mississippi, Oxford, Mississippi.

John Buckingham, Advisory Board, is the Co-founder and Chief Executive Officer of Solana MedSpas, the nation's foremost medical spa developer. Mr. Buckingham is a founding board member of the International Medical Spa Association and serves as their Vice President of Corporate Affairs. He has co-created, with the University of California, Irvine, a new Spa and Hospitality Management Certificate Program. As a pioneer in the Medical Spa and healthcare industry, Mr. Buckingham is a much sought after speaker and expert. Mr. Buckingham was recently featured in the Wall Street Journal, Fortune, New York Newsday, The Miami Herald, The Dallas Morning News, The Orange County Business Journal, Plastic Surgery News, American Spa Medical Spa Report, and MEDIcalSPAS The Healthy-Aging Business Review. Mr. Buckingham holds a Bachelor of Science in Pharmacy with distinction from Purdue University and a Master's in Business Administration from Harvard Business School.
 


Contacts

Corporate Headquarters
2687 McCollum Parkway
Suite 206
Kennesaw, GA 30144

Email: info@medspasofamerica.com
Investor Relations
Rich Kaiser
YES International

Phone: (866) 595-1081
Email: ir@medspasofamerica.com


FORWARD LOOKING STATEMENTS

This report includes forward-looking statements that reflect MedSpas of America, Inc. current expectations about its future results, performance, prospects and opportunities. MedSpas of America, Inc. has tried to identify these forward-looking statements by using words and phrases such as "may," "will," "expects," "anticipates," "believes," "intends," "estimates," "plan," "should," "typical," "preliminary," "we are confident" or similar expressions. These forward-looking statements are based on information currently available and are subject to a number of risks, uncertainties and other factors that could cause MedSpas of America, Inc.'s actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. These risks, uncertainties and other factors include, without limitation, the Company's growth expectations and ongoing funding requirements, and specifically, the Company's growth prospects with scalable customers, and those outlined above. Other risks include the Company's limited operating history, the Company's history of operating losses, consumers' acceptance, the Company's use of licensed technologies, risk of increased competition, the potential need for additional financing, the terms and conditions of any financing that is consummated, the limited trading market for the Company's securities, the possible volatility of the Company's stock price, the concentration of ownership, and the potential fluctuation in the Company's operating results.


Disclaimer

AllPennyStocks.com feature stock reports are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this report was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. For more information see our disclaimer section, a link of which can be found on our web site. This document contains forward-looking statements, particularly as related to the business plans of the Company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Actual results may differ materially from the Company's expectations and estimates. This is an advertisement for MedSpas of America, Inc. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.

© 1999-2007 AllPennyStocks.com. All rights reserved. AllPennyStocks.com is not a Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. All materials presented on our web site and individual reports released to the public through this web site, e-mail or any other means of transmission are not to be regarded as investment advice and are only for informative purposes. Before making a purchase or sale of any securities featured on our web site or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. As with any stock, companies we select to profile involve a degree of investment risk and volatility. Particularly Small-Caps and OTC-BB stocks. All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies. Past performance of our profiled stocks is not indicative of future results. The accuracy or completeness of the information on our web site or within our reports is only as reliable as the sources they were obtained from. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. AllPennyStocks.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our web site or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), AllPennyStocks.com will disclose in it's disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on the AllPennyStocks.com web site. AllPennyStocks.com has been compensated four thousand dollars by a non-affiliated third-party, SPC Consultants, LLC. for its efforts in presenting the MEDP profile on its web site and distributing it to its database of subscribers as well as other services. AllPennyStocks.com may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report. As of the profile date, no shares have been sold. Information presented on our web site and within our reports contain "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “expects’”, “will,” “anticipates,” “estimates, “believes,” or that by statements indicating certain actions “may,” “could,” or “might” occur.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at: http://www.sec.gov and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.

 

 

 


 

AllPennyStocks.com © 1999 - 2008. AllPennyStocks.com is a web publishing venture produced by AllPennyStocks.com Media, Inc.